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NKR-P1A is a lectinlike surface molecule expressed on rat natural killer (NK) cells. NKR-P1A 
has structural  and functional features of an activating NK cell receptor, but a requirement  for 
NKR-P1A in target cell lysis has not been determined. To define the role of NKR-PIA in natural 
killing,  we have generated a mutant  of the rat  NK cell line,  RNK-16,  lacking  expression of 
all members of the NKR-P1 receptor family. Although these NKR-Pl-deficient NK cells were 
able to kill many standard  tumor targets,  including  YAC-1,  they were selectively deficient in 
the lysis of IC-21  macrophage,  B-16 melanoma,  and C1498 lymphoma  targets.  Reexpression 
of a single member of the NKR-P1 family, NKR-PIA, on mutant cells restored lysis of IC-21, 
and killing  of IC-21  targets  through  rat  NKR-PlA  was completely blocked by F(ab')2  anti- 
NKR-PLA. Reexpression of NKR-PIA also restored transmembrane signaling to IC-21, as assessed 
by the generation of inositol-l,4,5-trisphosphate.  The generation of inositol-l,4,5-trisphosphate 
was also restored in response to B-16 targets, but both B-16 and C1498 cells remained resistant 
to lysis, indicating that other NK cell molecules, perhaps within the NKR-P1 family, are required 
for the efficient killing of these tumors. These results are the first to demonstrate that NKR-PIA 
is a target-specific receptor that  activates natural  killing. 
N 
'K cells are large granular lymphocytes that  spontane- 
ously lyse certain tumors, vitally infected cells, and blast 
cells. The receptors on NK cells that  recognize target cells 
and thereby activate NK cells have not been defined (1).  In 
rats, candidates include the lectinlike molecules NKR-PIA, 
which can activate NK cell cytotoxicity (2, 3). The NKR-P1 
receptor family was defined by NKtL-P1A, a 60-kD type II 
integral membrane homodimer with an extracellular  calcium- 
dependent (C-type) lectin domain (2-4).  NKR-PIA is one 
member of a family of receptors,  at least three in number, 
identified by cDNA cross-hybridization (5, 6). mAb to NKR- 
P1A (3.2.3) binds to all rat NK cells and stimulates NK cyto- 
toxicity, phosphoinositide turnover, calcium mobilization, and 
degranulation (2, 7). The importance of NKtL-P1A in tumor 
lysis, however, is yet to be determined. A physiologic ligand 
for NKR-PIA has not been identified,  and mAb to NKR- 
PIA does not block cytotoxicity against standard targets such 
as YAC-1  (2,  7). 
To define the role of NKR-PIA in natural killing, we have 
used the rat NK cell line R.NK-16, which expresses NKR- 
PIA (7). After treatment of RNK-16 cells with the mutagen 
ethylmethane  sulfonate,  we isolated a variant cell line that 
lacked surface expression of NKR-P1A and, by Northern blot 
analysis,  lacked transcripts for all members of the NKR-P1 
family.  Functional  studies  using  this  NKR-PlA-deficient 
mutant line demonstrate that NKR-P1A is a target-specific 
receptor  that  activates natural  killing. 
Materials  and Methods 
Antibodies.  mAb 3.2.3 (anti-NKR-PlA),  3G7 (anti-gp42), and 
B22.249 (anti-H-2D b, cxl/cx2) were produced as ascites and were 
partially purified by precipitation  in 50%  saturated ammonium 
sulfate at 4~  for 18 h followed by dialysis against PBS. F(ab')2 
fragments were produced as previously described (7), and F(ab')2 
preparations were analyzed for completeness of digestion by SDS- 
PAGE. 
Cell Lines.  RNK-16, an NK cell leukemia line from F344 rats, 
was a gift from Craig Reynolds (National  Cancer Institute,  Na- 
tional Institutes of Health, Frederick, MD) (7). The MHC class I 
transfectants of C1498, termed C1498.D12, C1498.K18, C1498.D8, 
were reported previously (8) and were provided by Wayne Yoko- 
yama and Franz Karlhofer (Mount Sinai Medical Center, New York), 
as were the tumor targets KF.9, RBL-5, and RMA-S. The 51B colon 
carcinoma line (9) was obtained from Robert Bresalier (Henry Ford 
Hospital, Detroit, MI). The B-16 melanoma line was from Klas 
K~rre (Karolinska Institute, Stockholm, Sweden). The B22.249 hy- 
bridoma was supplied by David Raulet (University of California, 
Berkeley, CA). The PA317 and the ~z retroviral packaging lines 
were from Dan Littman (University of California, San Francisco, 
CA). All other tumors were obtained from the American Type Cul- 
ture Collection  (Rockville, MD). All cells were grown in corn- 
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U/ml], streptomycin [100 #g/ml], glutamine [2 raM], and 2-ME 
[50/zM]) at 37~  in a humidified 5%  CO2 atmosphere. 
Preparation of  Murine Blast Targets.  Con A-stimulated blast cells 
were generated as described (10). Fresh murine splenocytes  were 
adjusted to 2  x  106 cells/ml and cultured for 2-3 d in complete 
RPMI supplemented with 5/zg/ml of Con A. Before use as targets, 
cells were collected on Ficoll  to remove dead cells. 
Generation of NKR-PIA-deficient Mutants of RNK-16.  RNK- 
16.M13 mutants were derived as previously described (11). RNK-16 
cells were treated with ethylmethane sulfonate (200 #g/ml) in com- 
plete RPMI for 24 h. Cells were washed, and then allowed to grow 
for 3 d. They were then selected against the expression of the 3.2.3 
(NKR-P1A) antigen by flow sorting. After five rounds of negative 
selection, NKR-PlA-negative cells were cloned and then subcloned 
to limiting dilution. The cell surface phenotype of each clone was 
determined, and several clones were analyzed for NKR-P1 mRNA 
expression. 
Northern Blot Analysis.  Poly(A) + RNA was prepared by a vari- 
ation of the mRNA isolation protocol (Fast Track; Invitrogen, San 
Diego, CA) according to the manufacturer's instructions. 2/zg of 
poly(A) § RNA from each cell line was analyzed by Northern blot 
analysis according to standard methods (12). The RNA was resolved 
by gel electrophoresis  and transferred to a nitrocellulose membrane. 
A  32p-radiolabeled full-length  rat  NKR-PIA  cDNA  probe was 
generated using ~-[32p]dCTP  (3,000 Ci/mmol, Amersham Corp., 
Arlington Heights, IL) by using the Random Hexanucleotide Primer 
Labeling kit (Boehringer Mannheim Corp., Indianapolis,  IN) ac- 
cording to the manufacturer's instructions. After prehybridization, 
the membrane was incubated with the probe overnight at 42~ 
in hybridization solution (50% formamide, 6x SSC, 5x Denhardt's, 
1% SDS, and 50/xg/ml salmon sperm DNA) as described (12). 
The membrane was then washed at progressively higher stringency, 
with the final wash in 0.25x  SSC, 0.1% SDS, at 42~  As a con- 
trol, the blot was stripped by treatment with 1 mM EDTA at 95~ 
for 15 rain and reprobed with the glyceraldehyde-phosphate de- 
hydrogenase (GAPDH) cDNA. 
Transfection of RNK-16.M13  witk  the  Rat  NKR-P1A  cDNA. 
Reconstitution of NKR-PIA expression in RNK-16.M13 mutants 
was accomplished using the retroviral gene transfer system as de- 
scribed (13). Briefly, the full-length rat NKR-PIA cDNA was sub- 
cloned into the EcoRI site of the pMV7 expression  vector, which 
was then transfected into the packaging cell line ~  by using cal- 
cium phosphate precipitation (12). After 48 h, culture supernatants 
were used to infect PA317 packaging cells in 100-mm dishes in the 
presence of polybrene (8 #g/ml) for 2 h. Stably transfected PA317 
packaging lines were generated by selection in G418 (250/~g/ml 
in  complete  RPMI).  Supernatants  from  NKR-PIA-transfected 
PA317 cells were incubated with RNK-16.M13 cells in the pres- 
ence of polybrene. After 2 d, the RNK-16.M13 cells were selected 
in 300/zg/ml of G418 in complete RPMI. NKR-PIA-expressing 
cells were isolated and subcloned after ,,020 d in selection.  One 
clone, RNK-16.T18, exhibited a phenotype characteristic of  all high 
expressing transfectants. 
Cytotoxicity Assays.  Cytotoxicity was measured by using SlCr- 
release microcytotoxicity  assays as previously described in detail (7). 
For antibody-blocking studies,  F(ab')2 fragments (50/~g/106  effec- 
tors) were added to effectors at 20~  15 min before assays. 
Assays for Pkospkoinositide Turnover.  Assays  for inositol-l,4,5- 
trisphosphate  (InsP3)  were  performed exactly as  described  (7). 
Briefly, duplicate samples of 5  x  106 [3H]inositol-labeled NK cells 
were stimulated with 107 targets in a total volume of I  ml. The 
cells were rapidly pelleted and resuspended in 1 ml of 10% TCA. 
The [3H]InsP3 from each sample was extracted with diethyl ether 
and resolved by ion exchange chromatography on Dowex Ag 1-X8 
(Bio-Rad  Laboratories,  Hercules, CA). 
Results  and  Discussion 
RNK-16 cells were treated with the mutagen ethylmethane 
sulfonate and  sdected against  the surface expression of rat 
NKR-P1A.  Eight cloned cell lines lacked detectable surface 
expression of NKR-PLA. One line, RNK-16.M13, also lacked 
detectable mRNA transcripts for all members of the NKR-Pl 
family (Fig. 1). RNK-16.M13 expressed other surface mole- 
cules at normal levels, including CD2, CD45, and gp42 (not 
shown). 
RNK-16.M13 lysed most tumor targets, including YAC-1, 
with approximately the same effidency as the parent line (Table 
1).  Three targets that were susceptible to lysis by RNK-16, 
however, were not lysed by RNK-16.M13:IC-21 macrophage, 
C1498 lymphoma, and B-16 melanoma cells. Similar results 
were obtained with the seven other mutant RNK-16 clones 
that lacked NKR-PlA (not shown). Of note, IC-21, C1498, 
and B-16 were all derived from C57BL/6 mice (H-2b), and 
they were the only H-2  b targets  that  were killed by wild- 
type RNK-16.  Tumors from H-2  a or from (1-I-2  b  x  H-2a)F1 
mice were lysed equally by the parent and mutant cell lines, 
and  transfection of H-2  b C1498  lymphoma cells with  the 
cDNAs  encoding  H-2D  d,  H-2K  d,  or H-2L  a did  not  alter 
their susceptibility to lysis by either line. The H-2  b tumor 
target RBL-5 and its MHC-deficient mutant, RMA-S (14), 
were uninformative, since neither was lysed by RNK-16 or 
RNK-16.M13 ceils, nor were T  call blast targets from either 
C57BL/6  (H-2  b)  or BALB/c (H-2  d)  mice. 
The expression of NKR-PlA, the most abundant member 
of the NKR-P1  family, was restored on RNK-16.M13  cells 
by  retroviral  gene  transfer.  A  cloned  line,  RNK-16.T18, 
expressed NKR-P1A  at  a  level similar  to  that  on parental 
RNK-16 calls (Fig. 2). The killing of informative targets by 
RNK-16.T18,  RNK-16.M13,  and RNK-16 cells was exam- 
Figure  1.  Northern  blot  analysis of 
RNA from wild-type RNA-16 and the 
NKR-Pl--deficient  mutant RNK-16.M13. 
When probed with the full-length (1.0 
kb)  rat  NKR-PLA cDNA,  wild-type 
RNA-16 expresses  1.1 kb, 1.7 kb, and 2.4 
kb  NKR-Pl-related  mRNA  species. 
RNK-16.M13,  however, expresses no 
NKR-P1 transcripts. Both cells express 
similar amounts of control  GAPDH 
mRNA. 
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RNK-16  RNK-16.M13 
Cell line  Type  H-2  40  20  10  5  40  20  10  5 
E/T ratio  E/T ratio 
YAC-1  Lymphocytes  a  69  64  56  43  44  36  30  18 
RLo" 1  Lymphoma  d  69  64  51  38  65  64  49  30 
P388.D1  Macrophage  d  71  58  51  37  27  18  12  8 
51B  Carcinoma  d  46  41  36  29  42  38  34  25 
RAW.309  Macrophage  b  ￿  d  20  19  17  12  13  6  4  3 
IC-21  Macrophage  b  30  27  23  19  6  5  6  6 
B-16  Melanoma  b  28  23  17  13  5  4  4  4 
C1498  Lymphoma  b  31  30  24  17  0  0  0  0 
C1498.D12  Lymphoma  b  +  D a  49  43  34  21  0  0  0  0 
C1498.K18  Lymphoma  b  +  K  a  38  33  25  17  0  0  0  0 
C1498.L8  Lymphoma  b  +  L  d  39  37  28  18  0  0  0  0 
KF.9  Lymphoma  b  6  5  3  2  0  0  0  0 
TIMI.4  Lymphoma  b  1  1  1  1  2  2  2  1 
RBL 5  Lymphoma  b  1  2  1  3  0  0  0  0 
RMA-S  Lymphoma  b-  1  1  1  0  0  0  0  0 
P815  Mastocytoma  d  9  7  4  1  2  1  1  0 
R1.1  T  cell  k  2  3  3  1  0  0  1  0 
BW5147.3  T  cell  k  4  5  6  5  4  3  3  2 
BALB/c  T  blast*  d  5  3  1  1  0  0  0  0 
C57BL/6  T  blast*  b  4  3  3  1  0  0  0  0 
Mutational loss of NKR-P1 by RNK-16 cells is accompanied by loss of cytotoxicity against  selected targets.  Lysis of most targets  by RNK-16 and 
NKR-Pl-deficient RNK-16.M13 was similar.  NKR-Pl-deficient RNK-16.M13, however, was selectively unable  to kill IC-21, B-16, and C1498. 
Transfection of C1498  with the cDNAs encoding H-2D  d (C1498.D12),  H-2K  d (C1498.K18),  or H-2L  d (C1498.L8)  did not alter  susceptibility  to 
lysis by either effector.  RBL-5 and its MHC class I-deficient mutant,  RMA-S (8), were uninformative targets,  since neither was killed.  Lysis of 
all tumor targets was examined at  E/T ratios  of 40:1,  20:1,  10:1,  and  5:1. 
* For T  cell blast  targets,  effectors were added  at  E/T ratios  of 100:1,  50:1,  25:1,  and  12.5:1. 
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Figure  2.  NKR-PIA-specific cell surface staining of wild-type RNK- 
16,  RNK-16.M13,  and  RNK-16.T.18 by flow cytometry.  R.NK-16.M13 
mutant cells (M.13)  express no cell surface NKR-PIA as determined  by 
staining with the 3.2.3 mAb. NKIL-PIA-transfected mutants ILNK-16.T18 
(T18,  shaded)  express NKR-PIA at levels comparable  to those of wild- 
type RNK-16 (WT). Expression  of CD45, CD2, and gp42 was similar 
ined (Fig. 3, A-D). Killing of YAC-1 targets by RNK-16.T18 
was equal to killing by RNK-16.M13 cells.  (In the experi- 
ment presented, killing of YAC-1 by both lines was less than 
by RNK-16,  but  this was not regularly the case.)  Killing 
of IC-21 cells,  not seen with RNK-16.M13 cells,  was sub- 
stantially restored by expression of NKR-PIA on RNK-16.T18 
cells.  Thus,  NKR-P1A is necessary and  sufficient for lysis 
of IC-21. Other members of the NKR-P1 family, however, 
might also have this capability.  In support of this,  F(ab~ 
antibody to NKfL-P1A completely blocked killing of IC-21 
by RNK-16.T18 cells, but it had no effect on killing of IC-21 
by parent RNK-16 cells,  which express all members of the 
in all lines (not shown). None of the cell lines stained with various control 
antibodies,  including antibodies  against  rat CD3 (not shown). 
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Figure  3.  Cytotoxicity  (A-F) by 
wild-type RNK-16, RNK-16.M13, 
and  RNK-16.T18  cells.  NK  cell 
cytotoxicity  was  tested  against 
YAC-1 (A), C1498 (B), B-16 (C), 
and IC-21 (D-F)  tumors. YAC-1 
(.4) was killed by wild-type KNK- 
16 (O), RNK-16.M13 mutant cells 
(0), and by NKR-PlA-transfected 
RNK-16.T18 (ll). C1498 (B) was 
lysed by RNK-16, not by RNK- 
16.M13,  and  weakly by  KNK- 
16.T-18. B-16 (C)  was  lysed by 
RNK-16, not by RNK-16.M13, and 
not by RNK-16.T18. IC-21 (D) was 
killed  by  RNK-16, and  not  by 
RNK-16.M13, but was lysed  by the 
RNK-16.T18 transfectants.  Ly~is of 
IC-21 by RNK-16 (O, E) was not 
blocked  by F(ab')2 3.2.3 (A,  E). 
Killing  of IC-21 by RNK-16.T18 
(i, F), however,  was completely 
blocked by F(ab')2 3.2.3 (A, F), 
but not by F(ab')2 B22.249 (anti- 
H-2D b,  cq/t~z) or  F(ab')2 3G7 
(anti-gp42)  (not  shown). 
NKR-P1 family (Fig. 3, E-F). We conclude that NKR-P1A 
is a specific receptor  for IC-21 but that other members of 
the NKR-P1  family can  also  serve  this function. 
Killing of C1498 or B-16 cells, in contrast to IC-21 cells, 
was not substantially restored by expression of NKR-PIA; 
in each of three experiments, killing was either absent or was 
only slightly above baseline (Fig. 3, B and C). Thus, NKR- 
P1A alone cannot significantly restore the lyric response to 
these two  targets. 
As another assay for the NK response to targets, we next 
examined polyphosphoinositide turnover, an early transmem- 
brahe  signal  in  NK  cell  activation  (7).  The generation  of 
InsP3 by RNK-16 cells in response to target cells was com- 
pared  to  the  generation  of  InsP3  by  RNK-16.M13  and 
RNK-16.T18  cells  (Fig.  4, A-C). All  three  NK  cell  lines 
demonstrated a brisk response to YAC-1, consistent with the 
demonstration that NKR-PIA is not required for lysis of this 
target.  Both IC-21  and B-16 cells stimulated a response in 
RNK-16 cells that was absent in RNK-16.M13 cells and was 
restored in RNK-16.T18  cells.  The response to C1498 was 
too low in all cell lines  to detect  significant  changes.  The 
response to IC-21 is thus concordant with cytotoxicity, but 
NKR-P1A  restores  the inositol  response  to B-16  without 
restoring killing. Additional signals are apparently needed for 
lysis  of B-16,  perhaps  supplied  by  other  members  of the 
NKR-P1  family. 
The NKR-P1 gene family is part of a superfamily of lec- 
tinlike receptors that are genetically  linked (15-18).  In the 
mouse, these include the Ly-49 family, whose ligands include 
class I MHC antigens.  Ly-49A binds to H-2D a and, in con- 
trast to NKR-P1A,  inactivates cytotoxicity (8,  19, 20). The 
specificity of Ly-49A for class I MHC antigens and the in- 
ability of RNK-16.M13  cells to lyse H-2 b targets raised the 
possibility that NKR-P1A might specifically  recognize class 
I  MHC  antigens  of  the  H-2 b haplotype.  Lysis  of  these 
targets,  however, was not blocked by F(ab')2 antibody to the 
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Figure  4.  Tumor-induced lnsP3 
generation by RNK-16 (tl), RNK- 
16.M13 (B), and RNK-16.T18 (C). 
NK cell lines were stimulated with 
VAC-1 (e), ]c-21 (B), Bq6 (A), 
C1498 (A), or medium alone (I-l). 
RNK-16 (A) responded briskly to 
YAC-1 (0), IC-21 (.), and B-16 
(A),  and  responded  weakly  to 
C1498 (&). RNK-16.M13 (B) was 
stimulated by YAC-I, but not by 
IC-21, B-16, or C1498. RNK-16.T18 
(C) was stimulated by YAC-1, IC-21, 
and B-16, and was minimally  stimu- 
lated by C1498. Thus, NKR-PIA restores  inositol signaling in response to IC-21,  and it restores  inositol  signaling but not killing in response  to B-16. 
Signaling  in response  to C1498 by all three  NK cell lines was too  low to  detect  significant changes. 
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were killed by NKR-1A + cells (Table 1). Also, recent studies 
of human NK clones have not shown a correlation between 
response to class I  antigens  and the expression of a human 
homologue of NKR-PIA (18). Resolution of this issue will 
require isolation of the ligands  for NKR-PIA.  Although  a 
physiologic ligand for NKR-PLA has not yet been fully charac- 
terized, soluble preparations of the rat NKR-PIA lectin do- 
main can bind to specific monosaccharides and neoglycocon- 
jugates  (4).  IC-21  targets  should  be  a  fruitful  source  for 
characterization  of a  natural ligand  for NKR-P1A. 
Our  studies  are the first to demonstrate a target-specific 
receptor that activates natural killing. The superfamily oflec- 
tinlike receptors on NK cells thus includes sped  fie receptors 
that can either activate (NKR-P1) or inhibit (Ly-49) lysis by 
NK cells in response to specific ligands on target cells. The 
NKR-P1 family appears to provide specificity for only a limited 
range of targets.  It is likely that other specific receptors re- 
main to be identified, perhaps within the superfamily of NK 
lectinlike receptors. 
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